JP4887674B2 - Method for producing phospholipid composition - Google Patents
Method for producing phospholipid composition Download PDFInfo
- Publication number
- JP4887674B2 JP4887674B2 JP2005199289A JP2005199289A JP4887674B2 JP 4887674 B2 JP4887674 B2 JP 4887674B2 JP 2005199289 A JP2005199289 A JP 2005199289A JP 2005199289 A JP2005199289 A JP 2005199289A JP 4887674 B2 JP4887674 B2 JP 4887674B2
- Authority
- JP
- Japan
- Prior art keywords
- phospholipid
- weight
- exchange reaction
- base exchange
- concentration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 150000003904 phospholipids Chemical class 0.000 title claims description 78
- 239000000203 mixture Substances 0.000 title claims description 37
- 238000004519 manufacturing process Methods 0.000 title description 11
- 150000003905 phosphatidylinositols Chemical class 0.000 claims description 44
- 238000006243 chemical reaction Methods 0.000 claims description 41
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical group CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 claims description 26
- 238000000034 method Methods 0.000 claims description 23
- JZNWSCPGTDBMEW-UHFFFAOYSA-N Glycerophosphorylethanolamin Chemical group NCCOP(O)(=O)OCC(O)CO JZNWSCPGTDBMEW-UHFFFAOYSA-N 0.000 claims description 19
- 150000008104 phosphatidylethanolamines Chemical group 0.000 claims description 19
- 102000011420 Phospholipase D Human genes 0.000 claims description 17
- 108090000553 Phospholipase D Proteins 0.000 claims description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 15
- 239000003960 organic solvent Substances 0.000 claims description 14
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims description 9
- 150000001875 compounds Chemical class 0.000 claims description 8
- 239000012454 non-polar solvent Substances 0.000 claims description 4
- 239000002798 polar solvent Substances 0.000 claims description 4
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims description 2
- TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 description 27
- ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 description 27
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 21
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 16
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- 239000002994 raw material Substances 0.000 description 13
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 11
- 238000003756 stirring Methods 0.000 description 11
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 8
- 230000000052 comparative effect Effects 0.000 description 8
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 8
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 7
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- 239000000787 lecithin Substances 0.000 description 6
- 235000010445 lecithin Nutrition 0.000 description 6
- -1 nitrogen-containing alcohols Chemical class 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 5
- 238000004128 high performance liquid chromatography Methods 0.000 description 5
- 229940067606 lecithin Drugs 0.000 description 5
- 239000008351 acetate buffer Substances 0.000 description 4
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 4
- FBOUIAKEJMZPQG-AWNIVKPZSA-N (1E)-1-(2,4-dichlorophenyl)-4,4-dimethyl-2-(1,2,4-triazol-1-yl)pent-1-en-3-ol Chemical compound C1=NC=NN1/C(C(O)C(C)(C)C)=C/C1=CC=C(Cl)C=C1Cl FBOUIAKEJMZPQG-AWNIVKPZSA-N 0.000 description 3
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 244000068988 Glycine max Species 0.000 description 3
- 235000010469 Glycine max Nutrition 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- 239000007853 buffer solution Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000012046 mixed solvent Substances 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- PORPENFLTBBHSG-MGBGTMOVSA-N 1,2-dihexadecanoyl-sn-glycerol-3-phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(O)=O)OC(=O)CCCCCCCCCCCCCCC PORPENFLTBBHSG-MGBGTMOVSA-N 0.000 description 2
- RGSFGYAAUTVSQA-UHFFFAOYSA-N Cyclopentane Chemical compound C1CCCC1 RGSFGYAAUTVSQA-UHFFFAOYSA-N 0.000 description 2
- NYHBQMYGNKIUIF-UUOKFMHZSA-N Guanosine Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O NYHBQMYGNKIUIF-UUOKFMHZSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- JCABVIFDXFFRMT-DIPNUNPCSA-N [(2r)-1-[ethoxy(hydroxy)phosphoryl]oxy-3-hexadecanoyloxypropan-2-yl] octadec-9-enoate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OCC)OC(=O)CCCCCCCC=CCCCCCCCC JCABVIFDXFFRMT-DIPNUNPCSA-N 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 229930014626 natural product Natural products 0.000 description 2
- FDPIMTJIUBPUKL-UHFFFAOYSA-N pentan-3-one Chemical compound CCC(=O)CC FDPIMTJIUBPUKL-UHFFFAOYSA-N 0.000 description 2
- 229920005862 polyol Polymers 0.000 description 2
- 150000003077 polyols Chemical class 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- JQWAHKMIYCERGA-UHFFFAOYSA-N (2-nonanoyloxy-3-octadeca-9,12-dienoyloxypropoxy)-[2-(trimethylazaniumyl)ethyl]phosphinate Chemical compound CCCCCCCCC(=O)OC(COP([O-])(=O)CC[N+](C)(C)C)COC(=O)CCCCCCCC=CCC=CCCCCC JQWAHKMIYCERGA-UHFFFAOYSA-N 0.000 description 1
- HXKKHQJGJAFBHI-UHFFFAOYSA-N 1-aminopropan-2-ol Chemical compound CC(O)CN HXKKHQJGJAFBHI-UHFFFAOYSA-N 0.000 description 1
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 1
- YKBGVTZYEHREMT-KVQBGUIXSA-N 2'-deoxyguanosine Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](CO)O1 YKBGVTZYEHREMT-KVQBGUIXSA-N 0.000 description 1
- 241001133760 Acoelorraphe Species 0.000 description 1
- 241000186361 Actinobacteria <class> Species 0.000 description 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 1
- 240000002791 Brassica napus Species 0.000 description 1
- 240000007124 Brassica oleracea Species 0.000 description 1
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 1
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 1
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 1
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- MIKUYHXYGGJMLM-GIMIYPNGSA-N Crotonoside Natural products C1=NC2=C(N)NC(=O)N=C2N1[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O MIKUYHXYGGJMLM-GIMIYPNGSA-N 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- NYHBQMYGNKIUIF-UHFFFAOYSA-N D-guanosine Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1OC(CO)C(O)C1O NYHBQMYGNKIUIF-UHFFFAOYSA-N 0.000 description 1
- 101000617550 Dictyostelium discoideum Presenilin-A Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 244000020551 Helianthus annuus Species 0.000 description 1
- 235000003222 Helianthus annuus Nutrition 0.000 description 1
- UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 description 1
- 229930010555 Inosine Natural products 0.000 description 1
- UBORTCNDUKBEOP-UHFFFAOYSA-N L-xanthosine Natural products OC1C(O)C(CO)OC1N1C(NC(=O)NC2=O)=C2N=C1 UBORTCNDUKBEOP-UHFFFAOYSA-N 0.000 description 1
- 208000026139 Memory disease Diseases 0.000 description 1
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 1
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- UBORTCNDUKBEOP-HAVMAKPUSA-N Xanthosine Natural products O[C@@H]1[C@H](O)[C@H](CO)O[C@H]1N1C(NC(=O)NC2=O)=C2N=C1 UBORTCNDUKBEOP-HAVMAKPUSA-N 0.000 description 1
- JLPULHDHAOZNQI-JLOPVYAASA-N [(2r)-3-hexadecanoyloxy-2-[(9e,12e)-octadeca-9,12-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C\C\C=C\CCCCC JLPULHDHAOZNQI-JLOPVYAASA-N 0.000 description 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- LFVGISIMTYGQHF-UHFFFAOYSA-N ammonium dihydrogen phosphate Chemical compound [NH4+].OP(O)([O-])=O LFVGISIMTYGQHF-UHFFFAOYSA-N 0.000 description 1
- 229910000387 ammonium dihydrogen phosphate Inorganic materials 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229940029575 guanosine Drugs 0.000 description 1
- 150000008282 halocarbons Chemical class 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- DMEGYFMYUHOHGS-UHFFFAOYSA-N heptamethylene Natural products C1CCCCCC1 DMEGYFMYUHOHGS-UHFFFAOYSA-N 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 229960003786 inosine Drugs 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- TYQCGQRIZGCHNB-JLAZNSOCSA-N l-ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(O)=C(O)C1=O TYQCGQRIZGCHNB-JLAZNSOCSA-N 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 235000019837 monoammonium phosphate Nutrition 0.000 description 1
- 229950006780 n-acetylglucosamine Drugs 0.000 description 1
- 239000002777 nucleoside Substances 0.000 description 1
- 125000003835 nucleoside group Chemical group 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 238000010979 pH adjustment Methods 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 125000001095 phosphatidyl group Chemical group 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 229940083466 soybean lecithin Drugs 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- UBORTCNDUKBEOP-UUOKFMHZSA-N xanthosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(NC(=O)NC2=O)=C2N=C1 UBORTCNDUKBEOP-UUOKFMHZSA-N 0.000 description 1
Images
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Fats And Perfumes (AREA)
Description
本発明は、ホスファチジルイノシトールと、ホスファチジルコリン及びホスファチジルエタノールアミンの塩基交換反応により得られるリン脂質との両方を高濃度で含有するリン脂質組成物を効率よく製造する方法に関する。 The present invention relates to a method for efficiently producing a phospholipid composition containing both phosphatidylinositol and a phospholipid obtained by a base exchange reaction of phosphatidylcholine and phosphatidylethanolamine at a high concentration.
リン脂質には、その種類に応じて様々な薬効があることが知られており、これまでに多くの研究がなされている。例えば、リン脂質の1種であるホスファチジルセリン(PS)には、記憶障害回復効果等の脳機能改善効果があることが報告されており(特許文献1参照)、ホスファチジルイノシトール(PI)は、中枢神経系障害の治療や代謝の改善に有効であることが報告されている(特許文献2、3参照)。
このように、これらのリン脂質はいずれも健康に重要なため、近年、2種以上のリン脂質を含有する製剤、特にPIとPS等との両方を高濃度で含有する製剤が市場で求められている。
Phospholipids are known to have various medicinal effects depending on their types, and many studies have been conducted so far. For example, it has been reported that phosphatidylserine (PS), which is one of phospholipids, has an effect of improving brain function such as memory disorder recovery effect (see Patent Document 1), and phosphatidylinositol (PI) is It has been reported that it is effective in treating nervous system disorders and improving metabolism (see Patent Documents 2 and 3).
Thus, since these phospholipids are all important for health, in recent years, a preparation containing two or more phospholipids, particularly a preparation containing both PI and PS at a high concentration has been demanded in the market. ing.
PS等は、ホスファチジルコリン(PC)をホスホリパーゼDの存在下でアルコール類と塩基交換反応させることにより得る方法が知られている。
例えば、高濃度のPSを得る方法としては、PCをホスホリパーゼDの存在下でセリンと反応させる方法が知られている(特許文献4参照)。PCの原料として大豆レシチン、卵黄レシチン等の天然材料を用いる場合、これらのレシチンにはPIも10%程度含まれているが、PSの収率を上げるために原料を精製してPCの濃度を上げるので、PIはごく微量となる。また、PIは、この反応ではPCのようにセリンと反応せず、むしろPCとセリンの反応を阻害する要因の一つとなっていることから、原料を精製して反応を行う必要があった。
A method is known in which PS or the like is obtained by base exchange reaction of phosphatidylcholine (PC) with alcohols in the presence of phospholipase D.
For example, as a method for obtaining a high concentration of PS, a method of reacting PC with serine in the presence of phospholipase D is known (see Patent Document 4). When natural materials such as soybean lecithin and egg yolk lecithin are used as raw materials for PC, these lecithins contain about 10% of PI. However, in order to increase the yield of PS, the raw materials are refined to increase the concentration of PC. Since it raises, PI becomes very trace amount. In addition, PI does not react with serine in this reaction like PC, but rather is one of the factors that inhibit the reaction between PC and serine. Therefore, it was necessary to purify the raw material and perform the reaction.
高濃度のPSを得る方法としては、また、高いホスファチジル基転移活性を有するホスホリパーゼDを用いる方法が報告されている(特許文献5参照)。この方法では、低純度のレシチンを精製することなく原料として用いることができるが、得られる組成物のPIの含量が充分ではなかった。 As a method for obtaining a high concentration of PS, a method using phospholipase D having high phosphatidyl group transfer activity has been reported (see Patent Document 5). In this method, low-purity lecithin can be used as a raw material without purification, but the PI content of the resulting composition is not sufficient.
一方、高濃度のPIを得る方法としては、植物由来のレシチンを含水低級アルコールを含む溶剤で処理し、更にエタノールを含む水溶液で処理して濃縮する方法が報告されている(特許文献6参照)。この方法では、PIを高濃度で得ることができるが、得られる組成物中のPS等の濃度が数%程度であった。 On the other hand, as a method for obtaining a high concentration of PI, a method has been reported in which plant-derived lecithin is treated with a solvent containing a water-containing lower alcohol and further treated with an aqueous solution containing ethanol to concentrate (see Patent Document 6). . In this method, PI can be obtained at a high concentration, but the concentration of PS or the like in the obtained composition was about several percent.
塩基交換反応により得られるPS等のリン脂質やPIを医薬品、食品として利用するには、それぞれ組成物中にPIが15%以上、PS等が20%以上含まれていることが必要である。従って、PS等とPIをともに高濃度で含有する組成物は、これまで別の製法で得られたPS等とPIとを混合することにより調製されていたが、PS等の製造とPIの製造に別の材料と工程が必要であるので、製造コストが高くなるという問題があった。
本発明は、上記現状に鑑み、ホスファチジルイノシトールと、塩基交換反応により得られるホスファチジルセリン等のリン脂質との両方を高濃度で含有するリン脂質組成物を効率よく製造する方法を提供する。 The present invention provides a method for efficiently producing a phospholipid composition containing a high concentration of both phosphatidylinositol and a phospholipid such as phosphatidylserine obtained by a base exchange reaction in view of the above-mentioned present situation.
本発明者らは、前述の課題を解決すべく鋭意検討を重ねた結果、リン脂質の塩基交換反応を行う際、予めリン脂質と溶媒を攪拌することにより、原料のリン脂質がホスファチジルイノシトールを比較的多く含んでいても塩基交換反応が効率よく進行し、ホスファチジルイノシトールと、塩基交換反応により得られるホスファチジルセリン等のリン脂質の両方を高濃度で含有するリン脂質組成物が簡便に得られることを見出した。 As a result of intensive studies to solve the above-mentioned problems, the present inventors compared the phosphatidylinositol with the raw material phospholipid by stirring the phospholipid and the solvent in advance when performing the base exchange reaction of the phospholipid. The base exchange reaction proceeds efficiently even if it contains a large amount, and a phospholipid composition containing both phosphatidylinositol and a phospholipid such as phosphatidylserine obtained by the base exchange reaction can be easily obtained. I found it.
すなわち、本発明は、ホスファチジルコリン及びホスファチジルエタノールアミンの少なくとも1種を合計で30重量%以上含み、かつホスファチジルイノシトールを10 重量%以上含むリン脂質を、有機溶媒及び水からなる二相系中で攪拌した後、ヒドロキシル基含有化合物及びホスホリパーゼDを添加して、ホスファチジルコリン及びホスファチジルエタノールアミンの少なくとも1種の塩基交換反応を行う工程からなる、リン脂質組成物の製造方法である。 That is, in the present invention, a phospholipid containing 30% by weight or more of phosphatidylcholine and phosphatidylethanolamine in total and 10% by weight or more of phosphatidylinositol was stirred in a two-phase system composed of an organic solvent and water. Then, it is a manufacturing method of a phospholipid composition which consists of the process of adding a hydroxyl-group containing compound and phospholipase D, and performing the base exchange reaction of at least 1 sort (s) of phosphatidylcholine and phosphatidylethanolamine.
以下に本発明を詳細に説明する。
本発明のリン脂質組成物の製造方法において、原料となるリン脂質としては、ホスファチジルコリン(PC)及びホスファチジルエタノールアミン(PE)の少なくとも1種を合計で30 重量%以上含み、かつホスファチジルイノシトール(PI)を10 重量%以上含むものを用いる。上記原料のリン脂質は、PC又はPEの何れかを30重量%以上含んでいればよいが、PC及びPEの両方を合わせて30重量%以上含んでいてもよい。好ましくは、PC及びPEの少なくとも1種の合計が、30〜60重量%であり、PIが10〜40重量%である。
The present invention is described in detail below.
In the method for producing a phospholipid composition of the present invention, the phospholipid used as a raw material includes a total of 30% by weight or more of phosphatidylcholine (PC) and phosphatidylethanolamine (PE), and phosphatidylinositol (PI). Using 10% by weight or more. The raw material phospholipid may contain 30% by weight or more of either PC or PE, but may contain 30% by weight or more of both PC and PE. Preferably, the total of at least one of PC and PE is 30 to 60% by weight, and PI is 10 to 40% by weight.
上記原料となるリン脂質は、いかなる起源のものでもよく、リン脂質を含む天然物、天然物からの抽出物、精製物、合成リン脂質等が挙げられる。具体的には、大豆、菜種、ひまわり、パーム由来のリン脂質等が挙げられ、大豆由来のものが好適である。このようなPIを比較的多く含むリン脂質の市販品としては、例えば、SLP−WHITE(PC25.6%、PE24.1%、ホスファチジル酸(PA)8%、PI12%、その他約30%)、SLP−PIパウダー(一例:PC18%、PE22%、PA8%、PI17%、その他約35%)(いずれも辻製油製)等が挙げられる。
従来の塩基交換反応では、収率を上げるために、原料となるリン脂質を精製してPC、PEの濃度を上げていたが、本発明の製造方法では、PC、PEの塩基交換反応により得られるホスファチジルセリン(PS)等と共にPIを多く含むリン脂質組成物を得ることを目的とすることから、PIを比較的多く含むリン脂質を原料に用いる。このようなPIを多く含むリン脂質としては、PC、PEを精製した時に発生するバイ・プロダクトも安価で好適である。
The phospholipid used as the raw material may be of any origin, and examples include natural products containing phospholipids, extracts from natural products, purified products, and synthetic phospholipids. Specific examples include soybean, rapeseed, sunflower, palm-derived phospholipids, and soybean-derived ones are preferred. Examples of commercially available phospholipids containing a relatively large amount of PI include, for example, SLP-WHITE (PC 25.6%, PE 24.1%, phosphatidylic acid (PA) 8%, PI 12%, other about 30%), SLP-PI powder (an example: PC18%, PE22%, PA8%, PI17%, other about 35%) (all are made by Sumi Oil).
In the conventional base exchange reaction, in order to increase the yield, the phospholipid used as a raw material is purified to increase the concentration of PC and PE. However, in the production method of the present invention, it is obtained by the base exchange reaction of PC and PE. In order to obtain a phospholipid composition containing a large amount of PI together with phosphatidylserine (PS) and the like, a phospholipid containing a relatively large amount of PI is used as a raw material. As such a phospholipid containing a large amount of PI, a by-product generated when PC and PE are purified is also inexpensive and suitable.
リン脂質の濃度は、後述の塩基交換反応時に5〜40重量%であることが好ましく、10〜30重量%がより好ましい。5重量%未満であると得られるリン脂質の量が少なく、40重量%を超えると塩基交換反応での転移率が低下する。 The concentration of the phospholipid is preferably 5 to 40% by weight and more preferably 10 to 30% by weight during the base exchange reaction described below. If the amount is less than 5% by weight, the amount of phospholipid obtained is small, and if it exceeds 40% by weight, the transfer rate in the base exchange reaction decreases.
本発明の製造方法では、ヒドロキシル基含有化合物及びPLDを添加してリン脂質の塩基交換反応を行う前に、リン脂質を有機溶媒及び水からなる二相系中で攪拌する。
上記有機溶媒としては特に限定されず、n−ヘプタン、n−ヘキサン、石油エーテル等の脂肪族炭化水素;シクロペンタン、シクロヘキサン等の環状脂肪族炭化水素;ジエチルエーテル、テトラヒドロフラン等のエーテル類;酢酸メチル、酢酸エチル等のエステル類;四塩化炭素、クロロホルム等のハロゲン化炭化水素類;アセトン、メチルエチルケトン、ジエチルケトン等のケトン類等を挙げることができる。これらは、1種又は2種以上を用いることができる。上記有機溶媒としては、極性溶媒及び非極性溶媒を含むものが好ましい。
In the production method of the present invention, the phospholipid is stirred in a two-phase system composed of an organic solvent and water before the hydroxyl group-containing compound and PLD are added to perform the base exchange reaction of the phospholipid.
The organic solvent is not particularly limited, and aliphatic hydrocarbons such as n-heptane, n-hexane, and petroleum ether; cycloaliphatic hydrocarbons such as cyclopentane and cyclohexane; ethers such as diethyl ether and tetrahydrofuran; methyl acetate And esters such as ethyl acetate; halogenated hydrocarbons such as carbon tetrachloride and chloroform; ketones such as acetone, methyl ethyl ketone, and diethyl ketone. These can use 1 type (s) or 2 or more types. As said organic solvent, what contains a polar solvent and a nonpolar solvent is preferable.
上記水としては、イオン交換水、精製水、蒸留水、水道水等が挙げられ、これらに酢酸等を含有させてpH調製のための緩衝液としてもよい。上記水としては、緩衝液を用いるのが好ましい。上記緩衝液の濃度は、0.1〜2.0Mが好ましく、0.4〜1.0Mがより好ましい。
上記二相系において、水の混合比は、有機溶媒に対して好ましくは20重量%以下であり、より好ましくは2〜15重量%、更に好ましくは5〜10重量%である。
Examples of the water include ion-exchanged water, purified water, distilled water, tap water, and the like. Acetic acid or the like may be contained in these to make a buffer solution for pH adjustment. As the water, a buffer solution is preferably used. The concentration of the buffer solution is preferably 0.1 to 2.0M, and more preferably 0.4 to 1.0M.
In the above two-phase system, the mixing ratio of water is preferably 20% by weight or less, more preferably 2 to 15% by weight, and further preferably 5 to 10% by weight with respect to the organic solvent.
上記二相系において、有機溶媒が極性溶媒及び非極性溶媒を含む場合、その混合比は特に限定されないが、好ましくは、極性溶媒:非極性溶媒が0.5:9.5〜5:5である。
このような有機溶媒及び水からなる二相系としては、例えば、ヘキサン:アセトン:水、ヘプタン:アセトン:水、ヘキサン:酢酸エチル:水の組み合わせ等が挙げられる。
In the above two-phase system, when the organic solvent contains a polar solvent and a nonpolar solvent, the mixing ratio is not particularly limited, but preferably the polar solvent: nonpolar solvent is 0.5: 9.5 to 5: 5 is there.
Examples of such a two-phase system composed of an organic solvent and water include a combination of hexane: acetone: water, heptane: acetone: water, hexane: ethyl acetate: water, and the like.
上記リン脂質の攪拌は、好ましくは10〜40℃、より好ましくは20〜30℃で行う。また、上記攪拌は、30分〜2時間行うことが好ましい。攪拌は一般的な攪拌機を用いることができる。攪拌の強度は特に制限はないが、液を上下に混合できる程度でよい。
本発明の方法において、上記リン脂質は、通常、有機溶媒に溶解した状態であり、上記攪拌により、リン脂質と有機溶媒及び水がエマルションを形成していてもよい。
Stirring of the phospholipid is preferably performed at 10 to 40 ° C, more preferably 20 to 30 ° C. The stirring is preferably performed for 30 minutes to 2 hours. For the stirring, a general stirrer can be used. The strength of stirring is not particularly limited, but may be such that the liquid can be mixed vertically.
In the method of the present invention, the phospholipid is usually in a state dissolved in an organic solvent, and the phospholipid, the organic solvent, and water may form an emulsion by the stirring.
本発明の製造方法では、有機溶媒及び水からなる二相系中でリン脂質を攪拌した後、ヒドロキシル基含有化合物及びホスホリパーゼD(PLD)を添加して、PC及び/又はPEの塩基交換反応を行う。
上記ヒドロキシル基含有化合物としては、アルコール類、含窒素アルコール類、糖類、ポリオール類、ヒドロキシ環状化合物等が挙げられる。
アルコール類としては、例えば、メタノール、エタノール、プロパノール、アスコルビン酸等が挙げられる。
含窒素アルコール類としては、例えば、セリンなどのアミノ酸;1−アミノ−2−プロパノールなどが挙げられる。
糖類としては、例えば、アデノシン、グアノシン、イノシン、キサントシン、デオキシアデノシン、デオキシグアノシン等のヌクレオシド;グルコース、トレハロース、N−アセチル−D−グルコサミン等が挙げられる。
ポリオール類としては、例えば、グリセロール、エチレングリコール、プロピレングリコール等が挙げられる。
ヒドロキシ環状化合物としては、例えば、麹酸、アルブチン等が挙げられる。
In the production method of the present invention, the phospholipid is stirred in a two-phase system composed of an organic solvent and water, and then a hydroxyl group-containing compound and phospholipase D (PLD) are added to perform a base exchange reaction of PC and / or PE. Do.
Examples of the hydroxyl group-containing compound include alcohols, nitrogen-containing alcohols, saccharides, polyols, and hydroxy cyclic compounds.
Examples of alcohols include methanol, ethanol, propanol, ascorbic acid and the like.
Examples of nitrogen-containing alcohols include amino acids such as serine; 1-amino-2-propanol.
Examples of the saccharide include nucleosides such as adenosine, guanosine, inosine, xanthosine, deoxyadenosine, deoxyguanosine; glucose, trehalose, N-acetyl-D-glucosamine and the like.
Examples of polyols include glycerol, ethylene glycol, propylene glycol and the like.
Examples of the hydroxy cyclic compound include succinic acid and arbutin.
本反応系中におけるヒドロキシル基含有化合物の濃度は、好ましくは20〜40重量%、より好ましくは25〜30重量%である。 The concentration of the hydroxyl group-containing compound in this reaction system is preferably 20 to 40% by weight, more preferably 25 to 30% by weight.
上記PLDとしては、リン脂質の塩基部分を加水分解することができるものであれば特に限定されず、例えば植物由来のPLD、微生物由来のPLD等が挙げられる。植物由来のPLDとしてはキャベツ、大豆由来のPLD等が挙げられ、微生物由来のPLDとしては放線菌、糸状菌由来のPLD等が挙げられる。
本反応系中におけるPLDの濃度は、リン脂質1gに対し、好ましくは5〜200U、より好ましくは20〜100Uである。なお、1Uは、95%大豆ホスファチジルコリンを基質とし、基質濃度0.16%の0.2M酢酸緩衝液(pH4.0、10mMのCaCl2、1.3%のTriton X−100を含む)を37℃にて反応させた時、1分間に1μmolのコリンを遊離する酵素量である。
The PLD is not particularly limited as long as it can hydrolyze the phospholipid base moiety, and examples thereof include plant-derived PLD and microorganism-derived PLD. Examples of plant-derived PLD include cabbage and soybean-derived PLD, and examples of microorganism-derived PLD include actinomycetes, filamentous fungus-derived PLD, and the like.
The concentration of PLD in this reaction system is preferably 5 to 200 U, more preferably 20 to 100 U, with respect to 1 g of phospholipid. In addition, 1U uses 95% soybean phosphatidylcholine as a substrate, 37 M 0.2M acetate buffer (pH 4.0, 10 mM CaCl 2 , 1.3% Triton X-100) 37%. It is the amount of enzyme that liberates 1 μmol of choline per minute when reacted at ° C.
上記塩基交換反応は、pH3.5〜10の条件で行うことが好ましく、pH4〜9がより好ましい。また、反応温度は、10〜40℃が好ましく、20〜30℃がより好ましい。 The base exchange reaction is preferably performed under conditions of pH 3.5 to 10, and more preferably pH 4 to 9. Moreover, 10-40 degreeC is preferable and, as for reaction temperature, 20-30 degreeC is more preferable.
上記塩基交換反応により、リン脂質中のPC、PE等と、セリン等のヒドロキシル基含有化合物とが反応してPS等が得られる。PIは、通常、上記塩基交換反応においてヒドロキシル基含有化合物と反応しにくいので、原料のリン脂質に含まれるPIがほぼそのままリン脂質組成物に含まれる。
本発明の製造方法により得られるリン脂質組成物の例として、PI及びPSを含むリン脂質組成物以外に、PI及びホスファチジン酸を含むリン脂質組成物、PI及びホスファチジルエタノールを含むリン脂質組成物等が挙げられる。
By the base exchange reaction, PC and PE in the phospholipid react with a hydroxyl group-containing compound such as serine to obtain PS and the like. Since PI generally does not easily react with a hydroxyl group-containing compound in the base exchange reaction, PI contained in the raw material phospholipid is contained in the phospholipid composition almost as it is.
Examples of the phospholipid composition obtained by the production method of the present invention include a phospholipid composition containing PI and phosphatidic acid, a phospholipid composition containing PI and phosphatidylethanol, and the like in addition to the phospholipid composition containing PI and PS. Is mentioned.
塩基交換反応を行った後は、例えば加熱等の処理でPLDを失活させ、遠心分離法等により有機溶媒層と水層を分離して有機溶媒層を得たあと、有機溶媒を減圧下で除去することによって濃縮する。次いで、アセトン又はエタノールで晶析を行い、固液分離によって固形物を得、乾燥することにより本発明のリン脂質組成物を単離することができる。 After performing the base exchange reaction, for example, the PLD is deactivated by a treatment such as heating, and the organic solvent layer and the aqueous layer are separated by a centrifugal method or the like to obtain the organic solvent layer. Concentrate by removing. Next, the phospholipid composition of the present invention can be isolated by crystallization with acetone or ethanol, obtaining a solid by solid-liquid separation, and drying.
本発明のリン脂質組成物の製造方法では、リン脂質の塩基交換反応を行う前にリン脂質と溶媒を攪拌することにより、原料のリン脂質にPIが比較的多く含まれていても塩基交換反応が効率よく進行し、PIと、塩基交換反応により得られるPS等のリン脂質の両方を高濃度で含有するリン脂質組成物、好ましくはPIを15重量%以上、PS等を20重量%以上含むリン脂質組成物を効率よく製造することができる。本発明の方法では、PIとPS等のリン脂質を別に調製する必要がないことから、上記リン脂質組成物を工業的に安価で製造することが可能である。 In the method for producing a phospholipid composition of the present invention, the base exchange reaction is carried out by stirring the phospholipid and the solvent before the base exchange reaction of the phospholipid, even if the raw material phospholipid contains a relatively large amount of PI. Phospholipid composition containing a high concentration of both PI and phospholipids such as PS obtained by base exchange reaction, preferably containing 15% by weight or more of PI and 20% by weight or more of PS A phospholipid composition can be produced efficiently. In the method of the present invention, since it is not necessary to separately prepare phospholipids such as PI and PS, the phospholipid composition can be produced industrially at low cost.
以下に、実施例を示して本発明を更に詳細に説明するが、本発明はこれらの実施例に限定されるものではない。実施例中の「%」は、「重量%」を示す。
実施例1
SLP−PIパウダー(辻製油製)を濃度が10%になるようにへプタン:アセトン混合溶媒(85:15)90mlに溶解した後に、6mlの1M酢酸緩衝液(pH4.0)を加え、30℃にて2時間攪拌した(前処理)。
その後、水層にセリンを25%、PLD80U/レシチン(g)になるように添加し、水層量を17mlに調整した。30℃にて一晩攪拌し、反応させた後、2時間静置した。下層の水層を分離してから、上層の溶媒層を減圧濃縮した。濃縮液に対して3倍量のエタノールを加え、沈殿させた。沈殿物を乾燥したあとに、クロロホルム:メタノール(2:1)溶液に溶解し、リン脂質含量を高速液体クロマトグラフィー法(HPLC法)により下記の条件で分析を行った。表1に示すリン脂質組成物が得られた。
HPLC条件
使用カラム:ジーエルサイエンス社製 Unisil Q NH2(4.6mm I.D.×250mm)
移動相:アセトニトリル/メタノール/50mMリン酸二水素アンモニウム=1856/874/270
流速:1.3mL/分
検出:UV 205nm
また、転移率を図1に示す。なお、転移率は、下記式によって求められる値である。
転移率(%)=反応後PSの濃度/反応前(PC+PE)濃度×100
Hereinafter, the present invention will be described in more detail with reference to examples. However, the present invention is not limited to these examples. “%” In the examples indicates “% by weight”.
Example 1
After dissolving SLP-PI powder (manufactured by Sumi Seiyaku Co., Ltd.) in 90 ml of a heptane: acetone mixed solvent (85:15) to a concentration of 10%, 6 ml of 1 M acetate buffer (pH 4.0) was added, and 30 The mixture was stirred at 0 ° C. for 2 hours (pretreatment).
Then, 25% of serine was added to the aqueous layer so as to be PLD80U / lecithin (g), and the amount of the aqueous layer was adjusted to 17 ml. The mixture was stirred at 30 ° C. overnight for reaction, and allowed to stand for 2 hours. After the lower aqueous layer was separated, the upper solvent layer was concentrated under reduced pressure. Three times the amount of ethanol was added to the concentrated solution to cause precipitation. The precipitate was dried and then dissolved in a chloroform: methanol (2: 1) solution, and the phospholipid content was analyzed by the high performance liquid chromatography method (HPLC method) under the following conditions. The phospholipid composition shown in Table 1 was obtained.
HPLC conditions <br/> Column used: manufactured by GL Sciences Inc. Unisil Q NH 2 (4.6mm I.D. × 250mm)
Mobile phase: acetonitrile / methanol / 50 mM ammonium dihydrogen phosphate = 1856/874/270
Flow rate: 1.3 mL / min Detection: UV 205 nm
The transfer rate is shown in FIG. The transfer rate is a value determined by the following formula.
Transfer rate (%) = PS concentration after reaction / Before reaction (PC + PE) concentration × 100
比較例1
SLP-PIパウダー(辻製油製)を濃度が10%になるようにヘプタン:アセトン混合溶媒(85:15)90mlに溶解した後に、6mlの1M酢酸緩衝液(pH4.0)及びセリンを25%、PLD80U/レシチン(g)になるように添加し、水層容積を17mlに調整した後、30℃にて一晩攪拌し、反応させた。下層の水層を分離してから、上層の溶媒層を減圧濃縮した。濃縮液に対して3倍量のエタノールを加え、沈殿させた。沈殿物を乾燥したあとに、クロロホルム:メタノール(2:1)溶液に溶解し、リン脂質含量をHPLC法により実施例1と同じ条件で分析を行った。結果を表1及び図1に示す。
Comparative Example 1
After dissolving SLP-PI powder (manufactured by Sumi Seiyaku Co., Ltd.) in 90 ml of a heptane: acetone mixed solvent (85:15) so as to have a concentration of 10%, 6 ml of 1M acetate buffer solution (pH 4.0) and serine are 25%. PLD80U / lecithin (g) was added to adjust the volume of the aqueous layer to 17 ml, and the mixture was stirred overnight at 30 ° C. for reaction. After the lower aqueous layer was separated, the upper solvent layer was concentrated under reduced pressure. Three times the amount of ethanol was added to the concentrated solution to cause precipitation. After the precipitate was dried, it was dissolved in a chloroform: methanol (2: 1) solution, and the phospholipid content was analyzed by the HPLC method under the same conditions as in Example 1. The results are shown in Table 1 and FIG.
表1及び図1から明らかなように、塩基交換反応の前に攪拌(前処理)を行った実施例1の方が、前処理を行わなかった比較例1と比較してPC、PEからPSへの転移率がよく、実施例1で得られたリン脂質組成物中のPI濃度が15重量%を超え、かつPS濃度が20重量%を超えていた。 As is clear from Table 1 and FIG. 1, Example 1 in which stirring (pretreatment) was performed before the base exchange reaction was compared with Comparative Example 1 in which pretreatment was not performed, and from PC, PE to PS. The PI concentration in the phospholipid composition obtained in Example 1 exceeded 15% by weight, and the PS concentration exceeded 20% by weight.
実施例2
SLP-WHITE(辻製油製)を濃度が20%になるようにヘプタン:アセトン混合溶媒(75:25)90mlに溶解した後に、6mlの1M酢酸緩衝液(pH4.0)を加え、30℃にて2時間攪拌した(前処理)。
その後、水層にセリンを25%、PLD80U/レシチン(g)になるように添加し、水層量を17mlに調整した。30℃にて一晩攪拌し、反応させた後、2時間静置した。上層の溶液をクロロホルム:メタノール(2:1)で希釈し、HPLC分析により、転移率を求めた。結果は図2に示す。
Example 2
SLP-WHITE (manufactured by Tsuji Oil) was dissolved in 90 ml of a heptane: acetone mixed solvent (75:25) to a concentration of 20%, and then 6 ml of 1 M acetate buffer (pH 4.0) was added, and the mixture was heated to 30 ° C. And stirred for 2 hours (pretreatment).
Then, 25% of serine was added to the aqueous layer so as to be PLD80U / lecithin (g), and the amount of the aqueous layer was adjusted to 17 ml. The mixture was stirred at 30 ° C. overnight for reaction, and allowed to stand for 2 hours. The upper layer solution was diluted with chloroform: methanol (2: 1), and the transfer rate was determined by HPLC analysis. The results are shown in FIG.
比較例2
攪拌(前処理)を行わずに反応を行う以外は、実施例2の同じ条件で反応、分析を行い、転移率を求めた。結果は図2に示す。
Comparative Example 2
Except for carrying out the reaction without stirring (pretreatment), the reaction and analysis were carried out under the same conditions as in Example 2 to obtain the transfer rate. The results are shown in FIG.
図2から明らかなように、塩基交換反応の前に攪拌(前処理)を行った実施例2の方が、前処理を行わなかった比較例2と比較してPC、PEからPSへの転移率がよかった。また、この転移率の違いは、リン脂質の濃度が20重量%の実施例2及び比較例2よりも、10重量%の実施例1及び比較例1の方が大きかった。 As is clear from FIG. 2, the transition from PC, PE to PS is more significant in Example 2 in which stirring (pretreatment) was performed before the base exchange reaction than in Comparative Example 2 in which pretreatment was not performed. The rate was good. Further, the difference in the transfer rate was larger in Example 1 and Comparative Example 1 having 10% by weight than in Example 2 and Comparative Example 2 having a phospholipid concentration of 20% by weight.
本発明のリン脂質組成物の製造方法では、リン脂質の塩基交換反応を行う前にリン脂質と溶媒を攪拌することにより、原料のリン脂質にPIが比較的多く含まれていても塩基交換反応が効率よく進行し、PIと、塩基交換反応により得られるPS等のリン脂質との両方を高濃度で含有するリン脂質組成物、好ましくはPIを15重量%以上、PS等を20重量%以上含むリン脂質組成物を効率よく製造することができる。このような組成物の例として、PI15重量%以上及びPS20重量%以上を含むリン脂質組成物以外に、PI20重量%以上及びホスファチジン酸20重量%以上を含むリン脂質組成物、PI18重量%以上及びホスファチジルエタノール20重量%以上を含むリン脂質組成物等が挙げられる。本発明の方法では、PIとPS等のリン脂質を別に調製する必要がないことから、上記リン脂質組成物を工業的に安価で製造することが可能である。
In the method for producing a phospholipid composition of the present invention, the base exchange reaction is carried out by stirring the phospholipid and the solvent before the base exchange reaction of the phospholipid, even if the raw material phospholipid contains a relatively large amount of PI. Phospholipid composition containing a high concentration of both PI and phospholipids such as PS obtained by base exchange reaction, preferably 15% by weight or more of PI and 20% by weight or more of PS The containing phospholipid composition can be produced efficiently. Examples of such compositions include, in addition to phospholipid compositions containing PI 15 wt% or more and
Claims (3)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2005199289A JP4887674B2 (en) | 2005-07-07 | 2005-07-07 | Method for producing phospholipid composition |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2005199289A JP4887674B2 (en) | 2005-07-07 | 2005-07-07 | Method for producing phospholipid composition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007014270A JP2007014270A (en) | 2007-01-25 |
| JP4887674B2 true JP4887674B2 (en) | 2012-02-29 |
Family
ID=37751969
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2005199289A Expired - Fee Related JP4887674B2 (en) | 2005-07-07 | 2005-07-07 | Method for producing phospholipid composition |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP4887674B2 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105087696A (en) * | 2015-10-13 | 2015-11-25 | 李桂华 | Preparation method suitable for industrialized continuous production of enzyme modified soybean phospholipids |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009110205A1 (en) | 2008-03-04 | 2009-09-11 | ナガセケムテックス株式会社 | Agent for increasing the quantity of hyaluronic acid |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1319679B1 (en) * | 2000-12-05 | 2003-10-23 | Chemi Spa | PHOSPHATIDYLSERINE PURIFICATION PROCESS. |
| JP4138597B2 (en) * | 2003-07-28 | 2008-08-27 | クノール食品株式会社 | Method for producing oil-in-water emulsion food with excellent heat resistance against oil separation |
| JP2005040041A (en) * | 2003-07-28 | 2005-02-17 | Knorr Foods Co Ltd | Antioxidant for food and oil-in-water emulsion food excellent in oxidation stability |
-
2005
- 2005-07-07 JP JP2005199289A patent/JP4887674B2/en not_active Expired - Fee Related
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105087696A (en) * | 2015-10-13 | 2015-11-25 | 李桂华 | Preparation method suitable for industrialized continuous production of enzyme modified soybean phospholipids |
| CN105087696B (en) * | 2015-10-13 | 2019-01-01 | 李桂华 | A kind of enzyme modified soybean lecithin industrialization quantity-produced preparation method |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2007014270A (en) | 2007-01-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69613801T2 (en) | Process for the industrial production of phosphatidylserines | |
| ES2206099T3 (en) | A PROCEDURE FOR THE PREPARATION OF FOSFATIDILSERINAS. | |
| AU779636B2 (en) | A method for preparing lysophosphatidylethanolamine | |
| JP4887674B2 (en) | Method for producing phospholipid composition | |
| RU2289625C2 (en) | Method for production of pure phosphides and uses thereof in cosmetic, pharmaceutics, and food | |
| IL187749A (en) | Process for the preparation and isolation of phosphatidylserine | |
| JP2002193982A (en) | Method for purifying phosphatidyl serine | |
| EP2862937A1 (en) | Method for producing phospholipid-containing composition, and phospholipid-containing composition | |
| JP3032357B2 (en) | Fractionation and purification method of phospholipid fraction | |
| US6635456B2 (en) | Procedure for the preparation of pure phosphatides with phospholipase D | |
| CN111788312B (en) | Method for manufacturing cyclic sodium phosphatidate | |
| US7709238B2 (en) | Method for removing enzyme and method of base exchange or hydrolysis of phospholipid using the same | |
| JP2009148244A (en) | Method for producing lysophosphatidylethanolamine | |
| JP5526467B2 (en) | Method for producing ceramide | |
| KR101973593B1 (en) | Process for Preparing Sodium Cyclic Phosphatidic Acid and Composition Comprising the Same | |
| JPH06228170A (en) | Phosphatidyl chromanol derivative, method for producing the same, antioxidant and emulsifier | |
| HK40039875B (en) | Method for preparing sodium cyclic phosphatidic acid | |
| JP2005261388A (en) | Method for producing lysophosphatidylglycerol | |
| JPS6188886A (en) | Preparation of phospholipid long-chain alcohol derivative by enzymatic process | |
| JP2007110951A (en) | Base exchange method of phospholipid | |
| RU2635665C1 (en) | METHOD FOR OBTAINING OF COMPENDIAL GRADE L-a-GLYCEROPHOSPHORYLCHOLINE | |
| JP2009268374A (en) | Method for producing lysophosphatidylethanolamine | |
| KR101055094B1 (en) | Biosynthesis Method of Phosphatidylserine from Egg Yolk Phospholipids by Cabbage Phospholipase D | |
| JP3529843B2 (en) | Method for producing aromatic phospholipid derivative | |
| JP2003169692A (en) | Method for producing phospholipid derivative or its salt |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20080627 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20110222 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110419 |
|
| RD02 | Notification of acceptance of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7422 Effective date: 20110419 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20111115 |
|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20111128 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 4887674 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20141222 Year of fee payment: 3 |
|
| LAPS | Cancellation because of no payment of annual fees |